Newsummit Biopharma Holdings

Healthcare ITSeries AShanghai, Chinanewsummitbio.com

Latest round

Series A

Last raised

Jun 2010

Total raised

$13M

Investors

3

About Newsummit Biopharma Holdings

Newsummit Biopharma Holdings Limited, based in China, is a drug development process solution provider. The firm's main business is to provide technology service for new drug research and development.

Who invested in Newsummit Biopharma Holdings

3 investors across 1 round

See all investors in Newsummit Biopharma Holdings

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jun 1, 2010

    Amount

    $13M

    Investors

    Locked

Questions about Newsummit Biopharma Holdings

Who invested in Newsummit Biopharma Holdings?

Newsummit Biopharma Holdings has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Newsummit Biopharma Holdings raised?

Newsummit Biopharma Holdings has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Newsummit Biopharma Holdings last raise money?

Newsummit Biopharma Holdings's most recent round on record is a Series A, in Jun 2010.

What does Newsummit Biopharma Holdings do?

Newsummit Biopharma Holdings Limited, based in China, is a drug development process solution provider.

Where is Newsummit Biopharma Holdings headquartered?

Newsummit Biopharma Holdings is headquartered in Shanghai, China.

Which VCs invest in companies like Newsummit Biopharma Holdings?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare it companies at Newsummit Biopharma Holdings's stage. Their profiles are linked below.

Raising like Newsummit Biopharma Holdings? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.